Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 9, 2017

Primary Completion Date

June 1, 2017

Study Completion Date

July 17, 2017

Conditions
Low Bone DensityOsteopeniaOsteoporosis, Postmenopausal
Interventions
DIETARY_SUPPLEMENT

Strontium L-lactate

The Study Product was a highly pure form of SrLac, the strontium salt of L-lactic acid. SrLac was manufactured in compliance with current Good Manufacturing Practices. SrLac was thoroughly tested and met rigorous purity specifications. It was free from contamination by D-lactic acid and trace metals known to harm human health.

Trial Locations (1)

60101

Biofortis Innovation Services, Addison

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biofortis Innovation Services

INDUSTRY

collaborator

NMS Laboratories

UNKNOWN

lead

BioLink Life Sciences, Inc.

INDUSTRY

NCT03761979 - Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults | Biotech Hunter | Biotech Hunter